Ferinject®

DRUG2 trials

Sponsors

National Cancer Center, Korea, Samsung Medical Center

Conditions

AnemiaCancer

Phase 2

The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients

Samsung Medical CenterAnemia, Cancer

Start: 2015-09-12End: 2017-12-31Target: 100Updated: 2017-02-09

Phase 3

Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)

CompletedNCT01725789

National Cancer Center, KoreaAnemia

Start: 2012-11-30End: 2016-04-30Updated: 2016-12-16

Related Papers

Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea

PLoS Medicine2020-06-0819 citations

Prospsective phase II pilot study to evaluate the use of intravenous iron in the treatment of anemia in cancer patients.

Journal of Clinical Oncology2018-05-20

Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy

JAMA2017-05-2384 citations

FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized controlled trial.

2014-04-057 citations